0
Your cart

Your cart is empty

Books > Business & Economics > Finance & accounting > Finance > Investment & securities > Stocks & shares

Buy Now

Biotechnology Valuation - An Introductory Guide (Hardcover, New) Loot Price: R1,956
Discovery Miles 19 560
Biotechnology Valuation - An Introductory Guide (Hardcover, New): KD Keegan

Biotechnology Valuation - An Introductory Guide (Hardcover, New)

KD Keegan

 (sign in to rate)
Loot Price R1,956 Discovery Miles 19 560 | Repayment Terms: R183 pm x 12*

Bookmark and Share

Expected to ship within 12 - 19 working days

The first book to provide a simple and practical means of valuing biotech companiesThe book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dipsIt examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the USLooks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical technology company) and gives tools for the investor to properly evaluate themPraise for "Biotechnology Valuation"

"Keegan states that the valuation of Biotech companies is as much an art as a science. This brief but comprehensive review of the skills and knowledge required, not of just the financial market and sentiment, but also of the technical attributes of a company and the drug development and regulatory hurdles that must be overcome, highlights the importance of the breadth of understanding required. Biotech investing is not for the timid, but it can bring substantial returns. Keegan's book, punctuated with his personal experience and opinions, is a good place to start."--Chris Blackwell, Chief Executive, Vectura Group plc

"A user-friendly, yet thorough discussion of a notoriously difficult topic. Dr Keegan's book is a fine resource for both business types and academicians."--Steve Winokur, Managing Director, CanaccordAdams

"A highly readable and comprehensive explanation of the technical and commercial parameters that influence biotechnology companies at all stages of development, providing clear context for selection from the toolkit of valuation methodologies the author recommends to assess company and product performance, or ascribe value."--Dr L.M. Allan, Director, Bioscience Enterprise Programme, University of Cambridge

"A fabulous approach to a difficult topic."--Deirdre Y. Gillespie, MD, President & CEO, La Jolla Pharmaceutical Company

General

Imprint: John Wiley & Sons
Country of origin: United States
Release date: November 2008
First published: 2009
Authors: KD Keegan
Dimensions: 244 x 170 x 14mm (L x W x T)
Format: Hardcover
Pages: 218
Edition: New
ISBN-13: 978-0-470-51178-7
Categories: Books > Business & Economics > Finance & accounting > Finance > Investment & securities > Stocks & shares
Books > Money & Finance > Investment & securities > Stocks & shares
Promotions
LSN: 0-470-51178-8
Barcode: 9780470511787

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Badass Trader - How To Trade Your Way To…
Robert J Van Eyden Paperback R310 R286 Discovery Miles 2 860
Girls That Invest: Your Guide to…
Simran Kaur Paperback R485 R441 Discovery Miles 4 410
Making Money From Stocks and Shares - A…
Jamie E. Smith Paperback R444 Discovery Miles 4 440
PLP_Supply Chain Management:Strategy…
Sunil Chopra Digital product license key R1,995 Discovery Miles 19 950
Employee Share Ownership and Impacts on…
Sara Elouadi Hardcover R6,704 Discovery Miles 67 040
Stocks And Forex Trading: How To Win
Daryl Guppy, Karen Wong Paperback R873 Discovery Miles 8 730
Stocks for the Long Run: The Definitive…
Jeremy Siegel Hardcover R874 Discovery Miles 8 740
Security Analysis
Benjamin Graham, David Dodd Hardcover R1,691 R1,321 Discovery Miles 13 210
Top Stocks 2016 - A Sharebuyer's Guide…
Martin Roth Paperback R506 R405 Discovery Miles 4 050
Get Started in Shares - Trading for the…
Glen Arnold Paperback R500 Discovery Miles 5 000
Managed Futures for Institutional…
Burghardt Hardcover R1,629 R1,335 Discovery Miles 13 350
Arbitrage, Hedging, and Speculation…
Ephraim Clark, Dilip K. Ghosh Hardcover R2,914 Discovery Miles 29 140

See more

Partners